• Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit BioSpace Tue, 07 Jul 2026 03:47:20 GMT
• lineage cell therapeutics to present at b. riley securities 2026 mind, muscle & vision healthcare summit Investing News Network Mon, 06 Jul 2026 13:09:21 GMT
• price to book forward of lineage cell therapeutics, inc. – amex:lctx TradingView Sun, 05 Jul 2026 12:48:40 GMT
• Price to earnings forward of Lineage Cell Therapeutics, Inc. – AMEX:LCTX TradingView Sun, 05 Jul 2026 12:18:21 GMT
• price to sales forward of lineage cell therapeutics, inc. – amex:lctx TradingView Sun, 05 Jul 2026 08:48:36 GMT
• Form 4 Lineage Cell Therapeutics Inc For: 2 July By Investing.com Investing.com Canada Thu, 02 Jul 2026 21:46:48 GMT
• Lineage Cell (LCTX) director granted 125,000 options at $1.30 strike Stock Titan Thu, 02 Jul 2026 21:33:53 GMT
• Lineage Cell (LCTX) awards director Deborah Andrews 125K stock options Stock Titan Thu, 02 Jul 2026 21:02:27 GMT
• Lineage Cell Therapeutics (LCTX) director receives 125,000 stock options at $1.30 Stock Titan Thu, 02 Jul 2026 21:02:27 GMT
• Lineage Cell Therapeutics (LCTX) director awarded 125,000 stock options at $1.30 Stock Titan Thu, 02 Jul 2026 21:02:23 GMT
• Lineage Cell Therapeutics (LCTX) director granted 125,000 options at $1.30 strike Stock Titan Thu, 02 Jul 2026 21:02:04 GMT
• Lineage Cell Therapeutics reports Q1 2026 results, advances pipeline scanx.trade Wed, 01 Jul 2026 11:56:21 GMT
• Transcript: Lineage Cell Therapeutics Q1 2026 Earnings Conference Call Benzinga Wed, 01 Jul 2026 08:05:21 GMT
• Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 20:11:19 GMT
• Lineage Cell Therapeutics, Inc.(NYSEAM: LCTX) added to Russell 2000 Index marketscreener.com Mon, 29 Jun 2026 18:28:02 GMT
• Lineage Cell Therapeutics, Inc.(NYSEAM: LCTX) added to Russell 2500 Index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 3000E Growth Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• price to book forward of lineage cell therapeutics, inc. – lsx:a2pp89 TradingView Sat, 27 Jun 2026 23:16:27 GMT
• LCTX Edges Higher As Traders Focus On Tight Range Break timothysykes.com Fri, 26 Jun 2026 20:41:00 GMT
• lineage cell therapeutics, inc. actuals & estimates (dus:bt3) TradingView Thu, 25 Jun 2026 15:54:52 GMT
• lineage cell therapeutics inc. (lctx) q1 2026 earnings: eps miss weighs on pre-revenue biotech dars.gov.et Thu, 25 Jun 2026 15:40:17 GMT
• streamlined procurement and lean ap workflows drive efficiency at lineage cell therapeutics Traders Union Thu, 25 Jun 2026 15:25:22 GMT
• enterprise value to ebitda forward of lineage cell therapeutics, inc. – amex:lctx TradingView Thu, 25 Jun 2026 09:11:24 GMT
• lineage cell therapeutics inc (lctx) valuation: pe, pb & fair value analysis TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• Aardvark Therapeutics Leads The Charge With 2 Other Noteworthy Penny Stocks simplywall.st Wed, 24 Jun 2026 07:00:00 GMT
• lineage cell therapeutics inc (lctx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• lineage cell therapeutics inc (lctx) institutional confidence TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• 3 us small cap stocks tied to stable rates and funding risk simplywall.st Sat, 20 Jun 2026 17:39:55 GMT
• lctx q1 2026 earnings: eps misses estimates as clinical-stage biotech advances pipeline - earnings expansion phase dars.gov.et Fri, 19 Jun 2026 07:00:00 GMT
• lineage cell therapeutics inc (lctx) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 19:15:24 GMT
• Lineage Cell Therapeutics (LCTX) Stock Faces Mixed Analyst Target Changes After Fresh Coverage Yahoo Finance Thu, 18 Jun 2026 07:00:00 GMT
• Lineage Cell Therapeutics Inc (LCTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey Thu, 18 Jun 2026 06:12:43 GMT
• lineage cell therapeutics inc (lctx) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 03:30:52 GMT
• lineage cell therapeutics inc (lctx) institutional confidence TradingKey Thu, 18 Jun 2026 01:21:34 GMT
• Lineage Cell Therapeutics Inc (LCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk TradingKey Thu, 18 Jun 2026 01:19:18 GMT
• lineage cell therapeutics inc (lctx) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 01:06:22 GMT
• lineage cell therapeutics inc (lctx) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 22:15:19 GMT
• lineage cell therapeutics inc (lctx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 10:48:48 GMT
• lineage cell therapeutics inc (lctx) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• lineage cell therapeutics inc (lctx) institutional confidence TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• lineage cell therapeutics inc (lctx) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• lineage cell therapeutics inc (lctx) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• lineage cell therapeutics joins panel on novel treatments at clinical trials at the summit Traders Union Mon, 15 Jun 2026 18:40:19 GMT
• lineage cell shareholders reaffirm governance and executive pay The Globe and Mail Sat, 13 Jun 2026 07:00:00 GMT
• lineage cell shareholders reaffirm governance and executive pay TipRanks Fri, 12 Jun 2026 22:59:34 GMT
• Lineage Cell (NYSE: LCTX) investors back board, say-on-pay as OPC1 grant bid withdrawn Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• lctx q1 2026 earnings: eps miss reflects ongoing r&d investment - management tone analysis newsline.com Sun, 07 Jun 2026 09:32:41 GMT
• How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• lctx financials: revenue breakdown, margins & competitor comparison Intellectia AI Tue, 02 Jun 2026 06:53:32 GMT
• lineage cell therapeutics (lctx) price target increased by 14.58% to 5.61 MSN Fri, 29 May 2026 11:33:28 GMT
• lctx q1 2026 earnings: wider loss than expected amid ongoing pipeline development - earnings turnaround newsline.com Fri, 29 May 2026 07:00:00 GMT
• lctx stock price, quote & chart | lineage cell therapeutics in (nysearca:lctx) ChartMill Fri, 29 May 2026 07:00:00 GMT
• lctx q1 2026 earnings: missed estimates as r&d spending weighs on bottom line - healthcare earnings report The Legal Advocate Fri, 29 May 2026 05:44:05 GMT
• Lineage Cell Therapeutics (LCTX) Gains 3% as Biotech Sector Finds Support - Low Risk Entry Stocks dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• lineage cell therapeutics q1 2026 earnings: wider-than-expected loss as clinical-stage biotech continues pipeline investment - est... newsline.com Thu, 28 May 2026 07:00:00 GMT
• lineage cell therapeutics inc. (lctx) q1 2026 earnings: eps misses estimates amid pipeline progress, stock rises 3.08% - revenue g... newsline.com Thu, 28 May 2026 07:00:00 GMT
• lineage cell therapeutics spotlights ceo participation in fireside chat with hcwco at bioconnect Traders Union Thu, 28 May 2026 07:00:00 GMT
• lctx q1 2026 earnings: eps misses estimates as company advances cell therapy pipeline - profit recovery report The Legal Advocate Thu, 28 May 2026 03:38:24 GMT
• lineage cell therapeutics (lctx) price target increased by 14.58% to 5.61 MSN Tue, 26 May 2026 14:33:25 GMT
• lineage cell therapeutics inc. (lctx) q1 2026 earnings: miss on eps as clinical-stage biotech continues development - roa comparis... newsline.com Tue, 26 May 2026 07:00:00 GMT
• lineage cell therapeutics (lctx) slides 1.52% – testing key support near $1.23 - fear greed extreme newsline.com Mon, 25 May 2026 07:00:00 GMT
• LCTX Q1 2026 Earnings: Wider-than-expected loss as clinical-stage biotech advances pipeline - Segment Revenue Breakdown dars.gov.et Sat, 23 May 2026 07:00:00 GMT
• lineage cell therapeutics (lctx) price target increased by 14.58% to 5.61 MSN Fri, 22 May 2026 19:02:05 GMT
• Lineage reports positive 36-month findings on GA cell therapy Eyes On Eyecare Fri, 22 May 2026 07:00:00 GMT
• earnings preview: lctx to report financial results post-market on may 12 Moomoo Fri, 22 May 2026 00:30:09 GMT
• Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets Investing News Network Wed, 20 May 2026 14:40:14 GMT
• maxim group maintains lineage cell therapeutics(lctx.us) with buy rating, maintains target price $3 富途牛牛 Wed, 20 May 2026 14:17:29 GMT
• lineage cell therapeutics (lctx) price target increased by 14.58% to 5.61 MSN Tue, 19 May 2026 21:28:53 GMT
• lineage cell therapeutics, inc. common stock (ny: lctx FinancialContent Tue, 19 May 2026 00:00:00 GMT
• lineage cell therapeutics, inc. common stock (nyse:lctx) stock quote FinancialContent Mon, 18 May 2026 19:49:59 GMT
• lineage cell therapeutics (lctx) price target increased by 14.58% to 5.61 MSN Mon, 18 May 2026 06:49:34 GMT
• lineage cell therapeutics (lctx) price target increased by 14.58% to 5.61 MSN Sun, 17 May 2026 08:03:06 GMT
• lineage cell therapeutics featured in european pharmaceutical review report on scalable cell therapies Traders Union Thu, 14 May 2026 15:26:56 GMT
• lineage cell therapeutics, inc. common stock (ny: lctx FinancialContent Thu, 14 May 2026 14:40:24 GMT
• lineage cell therapeutics (lctx) price target increased by 14.58% to 5.61 MSN Thu, 14 May 2026 09:10:09 GMT
• Lineage Cell Therapeutics (LCTX) Returns To Loss In Q1 2026 Challenging Profitability Narratives simplywall.st Thu, 14 May 2026 07:00:00 GMT
• lineage cell therapeutics highlights r&d momentum amid losses TipRanks Thu, 14 May 2026 00:23:42 GMT
• q1 2026 lineage cell therapeutics inc earnings call transcript GuruFocus Wed, 13 May 2026 13:11:56 GMT
• lineage targets operations into q2 2028 as it launches cor1 and scales ilt1 manufacturing MSN Wed, 13 May 2026 12:10:52 GMT
• lineage cell therapeutics earnings missed by $0.02, revenue fell short of estimates Investing.com Nigeria Wed, 13 May 2026 07:57:13 GMT
• lineage cell therapeutics, inc. (amex:lctx) q1 2026 earnings call transcript Insider Monkey Wed, 13 May 2026 07:00:00 GMT
• lineage cell therapeutics highlights r&d momentum amid losses TipRanks Wed, 13 May 2026 07:00:00 GMT
• lineage cell therapeutics reports first quarter 2026 financial results and provides business update BioSpace Wed, 13 May 2026 06:13:38 GMT
• lineage cell therapeutics (lctx) reports q1 2026 earnings and st GuruFocus Wed, 13 May 2026 06:00:00 GMT
• lineage cell therapeutics inc (lctx) q1 2026 earnings call highl GuruFocus Wed, 13 May 2026 04:32:34 GMT
• is lineage cell therapeutics (lctx) overvalued after q1 2026 eps GuruFocus Wed, 13 May 2026 02:06:08 GMT
• lineage cell (lctx) receives funding to support operations throu GuruFocus Wed, 13 May 2026 01:18:45 GMT
• lineage cell therapeutics (lctx) reports q1 results and advancem GuruFocus Wed, 13 May 2026 00:27:25 GMT
• lineage cell therapeutics reports q1 eps (3c), consensus (2c) TipRanks Tue, 12 May 2026 22:50:11 GMT
• is lineage cell therapeutics (lctx) overvalued after q1 2026 eps GuruFocus Tue, 12 May 2026 22:34:51 GMT
• lctx: strong pipeline expansion and robust cash position support continued clinical and manufacturing progress TradingView Tue, 12 May 2026 22:10:13 GMT
• [10-q] lineage cell therapeutics, inc. quarterly earnings report Stock Titan Tue, 12 May 2026 20:15:47 GMT
• press release: lineage cell therapeutics reports first quarter 2026 financial results and provides business update Moomoo Tue, 12 May 2026 20:01:00 GMT
• cell therapy biotech for eye and spinal injuries funded into 2028 Stock Titan Tue, 12 May 2026 20:01:00 GMT
• Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Business Wire Tue, 12 May 2026 07:00:00 GMT
• Lineage Cell Therapeutics (LCTX) Reports Q1 2026 Earnings and St GuruFocus Tue, 12 May 2026 07:00:00 GMT
• lineage cell (lctx) reports q1 loss, lags revenue estimates Yahoo Finance Tue, 12 May 2026 07:00:00 GMT
• lctx: positive clinical results, pipeline expansion, and strong cash position highlight q1 2026 TradingView Tue, 12 May 2026 07:00:00 GMT
• lineage cell therapeutics earnings missed by $0.02, revenue fell short of estimates Investing.com Tue, 12 May 2026 07:00:00 GMT
• lineage cell therapeutics holds investor call after releasing first quarter 2026 results Traders Union Tue, 12 May 2026 07:00:00 GMT
• lineage cell (lctx) receives funding to support operations throu GuruFocus Tue, 12 May 2026 07:00:00 GMT
• lctx: pipeline expansion, manufacturing progress, and strong cash runway drive 2026 outlook TradingView Tue, 12 May 2026 07:00:00 GMT
• lineage cell therapeutics (nyse: lctx) reports higher q1 2026 revenue and continued r&d spend Stock Titan Tue, 12 May 2026 07:00:00 GMT
• lineage cell therapeutics (lctx) posts q1 2026 results and advances cell therapy pipeline Stock Titan Tue, 12 May 2026 07:00:00 GMT
• lineage cell therapeutics (lctx) reports q1 results and advancem GuruFocus Tue, 12 May 2026 07:00:00 GMT
• lineage cell therapeutics inc (lctx) q1 2026 earnings call highlights: strategic advances and ... by gurufocus Investing.com Canada Tue, 12 May 2026 07:00:00 GMT
• lineage cell therapeutics (nysearca:lctx) q1 2026 results: revenue miss and increased losses weigh on investor sentiment ChartMill Tue, 12 May 2026 07:00:00 GMT
• why lineage (lctx) might be the best kept secret in the market (+2.55%) 2026-05-11 - mcclellan summation newsline.com Mon, 11 May 2026 07:00:00 GMT
• Lineage Cell Therapeutics, Inc. (LCTX) Presents at FFB Retinal Therapeutics Innovation Summit - Slideshow Seeking Alpha Thu, 07 May 2026 07:00:00 GMT
• biotech lineage will discuss quarterly results and a business update may 12 Stock Titan Tue, 05 May 2026 12:00:00 GMT
• lineage cell therapeutics to report first quarter 2026 financial results and provide business update on may 12, 2026 Business Wire Tue, 05 May 2026 07:00:00 GMT
• ccorf initiates lineage cell therapeutics(lctx.us) with buy rating, announces target price $9 Moomoo Tue, 05 May 2026 07:00:00 GMT
• lctx maintained by d. boral capital -- price target at $3.00 GuruFocus Mon, 04 May 2026 16:37:41 GMT
• lineage cell therapeutics price target maintained with a $3.00/share by d. boral capital Moomoo Mon, 04 May 2026 13:39:00 GMT
• lineage cell therapeutics is maintained at buy by d. boral capital Moomoo Mon, 04 May 2026 13:39:00 GMT
• vision gains lasted 3 years after a single opregen treatment Stock Titan Mon, 04 May 2026 12:00:00 GMT
• 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026 Business Wire Mon, 04 May 2026 07:00:00 GMT
• lineage cell therapeutics presents 3-year phase 1-2a opregen trial results in geographic atrophy at summit Traders Union Mon, 04 May 2026 07:00:00 GMT
• opregen® 3 year results in patients with ga presented at foundation fighting blindness retinal innovation summit 2026 Investing News Network Mon, 04 May 2026 07:00:00 GMT
• lineage cell announces 36-month results from phase 1/2a study of rg6501 TipRanks Mon, 04 May 2026 07:00:00 GMT
• lineage cell therapeutics (nyse american: lctx) sets 2026 vote on directors, auditor and executive pay Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• lctx initiated coverage by canaccord genuity -- price target ann GuruFocus Tue, 28 Apr 2026 18:45:00 GMT
• lineage cell therapeutics (nyseamerican:lctx) earns buy rating from analysts at canaccord genuity group MarketBeat Tue, 28 Apr 2026 13:02:54 GMT
• canaccord genuity initiates coverage of lineage cell therapeutics (lctx) with buy recommendation MSN Tue, 28 Apr 2026 07:00:00 GMT
• niagen bioscience and 2 additional promising penny stocks for your consideration simplywall.st Wed, 15 Apr 2026 07:00:00 GMT
• lineage cell therapeutics (lctx) establishes new scientific advi GuruFocus Tue, 14 Apr 2026 02:59:44 GMT
• lineage cell therapeutics: scientific advisory board formed to advance cell therapy platform Pulse 2.0 Tue, 14 Apr 2026 02:43:57 GMT
• Lineage Cell Therapeutics forms advisory board, names clinical head Investing.com Mon, 13 Apr 2026 07:00:00 GMT
Lineage Cell Therapeutics, Inc(NYSE MKT:LCTX) 
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company's lead product candidates include OpRegen, a retinal pigment epithelium cell r...
Website: http://www.lineagecell.com
Full Time Employees: 50
CEO: Brian M. Culley
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends